- Home
- KROS vs BAND Comparison
KROS vs BAND Comparison
Compare KROS & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- BAND
- Stock Information
- Founded
- KROS 2015
- BAND 2000
- Country
- KROS United States
- BAND United States
- Employees
- KROS N/A
- BAND N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- BAND Computer Software: Prepackaged Software
- Sector
- KROS Health Care
- BAND Technology
- Exchange
- KROS Nasdaq
- BAND Nasdaq
- Market Cap
- KROS 565.0M
- BAND 473.2M
- IPO Year
- KROS 2020
- BAND 2017
- Fundamental
- Price
- KROS $15.62
- BAND $18.29
- Analyst Decision
- KROS Buy
- BAND Buy
- Analyst Count
- KROS 14
- BAND 6
- Target Price
- KROS $20.56
- BAND $20.80
- AVG Volume (30 Days)
- KROS 412.4K
- BAND 262.3K
- Earning Date
- KROS 11-05-2025
- BAND 10-30-2025
- Dividend Yield
- KROS N/A
- BAND N/A
- EPS Growth
- KROS N/A
- BAND N/A
- EPS
- KROS 0.47
- BAND N/A
- Revenue
- KROS $232,844,000.00
- BAND $758,106,000.00
- Revenue This Year
- KROS $5,998.31
- BAND $2.48
- Revenue Next Year
- KROS N/A
- BAND $13.24
- P/E Ratio
- KROS $33.74
- BAND N/A
- Revenue Growth
- KROS 85820.30
- BAND 14.51
- 52 Week Low
- KROS $9.12
- BAND $11.33
- 52 Week High
- KROS $72.37
- BAND $23.00
- Technical
- Relative Strength Index (RSI)
- KROS 57.13
- BAND 74.28
- Support Level
- KROS $15.34
- BAND $14.97
- Resistance Level
- KROS $15.85
- BAND $17.09
- Average True Range (ATR)
- KROS 0.45
- BAND 0.73
- MACD
- KROS -0.02
- BAND 0.26
- Stochastic Oscillator
- KROS 57.08
- BAND 91.46
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.